Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001178913-13-001102
Filing Date
2013-04-16
Accepted
2013-04-16 14:08:32
Documents
1
Period of Report
2013-04-14

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT zk1312957.html 4  
1 OWNERSHIP DOCUMENT zk1312957.xml 4 4033
  Complete submission text file 0001178913-13-001102.txt   5538
Mailing Address 2 ELZA STREET JERUSALEM L3 93706
Business Address 2 ELZA STREET JERUSALEM L3 93706 011 972-54-7909058
ORAMED PHARMACEUTICALS INC. (Issuer) CIK: 0001176309 (see all company filings)

EIN.: 980376008 | State of Incorp.: DE | Fiscal Year End: 0831
SIC: 2834 Pharmaceutical Preparations

Mailing Address 9 ALFASI JERUSALEM L3 92302
Business Address
Hexter Joshua (Reporting) CIK: 0001573235 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35813 | Film No.: 13763500